Talent Aortic Cuff Stent Graft System Compassionate Use Registry
NCT ID: NCT00604643
Last Updated: 2021-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NO_LONGER_AVAILABLE
EXPANDED_ACCESS
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TALENT Aortic Cuff Abdominal Stent Graft
Endovascular Aneurysm Repair
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient has a serious disease or condition
* No generally acceptable alternative for treating patient is available
* Patient has had the AneuRx stent graft system implanted \>= 30 days
* Patient has suboptimal outcome with the AneuRx stent graft system as evidenced by one or more of the following:
* Type I endoleak
* Type III endoleak (Proximal, modular)
* Loss of seal zone
* Proximal aortic neck diameter \>= 14mm and \<= 30mm
* Angle between axis of the suprarenal aorta and aneurysm neck is \<= 60 degrees
* Patient is able and willing to be available for 12,24,26,48 and 60 months post-procedure
Exclusion Criteria
* Arterial access cannot be crossed with a delivery system
* Excessive vessel tortuosity
* Excessive aortic calcification
* AneuRx stent graft system implanted within the last 30 days
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiovascular
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medtronic CardioVascular
Role: STUDY_DIRECTOR
Medtronic Cardiovascular
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baptist Hospital
Montgomery, Alabama, United States
Kaiser
Oakland, California, United States
O'Connor Hospital
San Jose, California, United States
Kaiser Hayward
Union City, California, United States
Penrose Healthcare
Colorado Springs, Colorado, United States
Hartford Hospital
Hartford, Connecticut, United States
Washington Hospital
Washington D.C., District of Columbia, United States
Morton Plant Hospital
Clearwater, Florida, United States
North Florida Regional Medical Center
Gainesville, Florida, United States
University of Florida
Gainesville, Florida, United States
Munroe Regional Medical Center
Ocala, Florida, United States
JA Haley Veterans Hospital
Tampa, Florida, United States
St. Joseph's Hospital
Atlanta, Georgia, United States
Gwinnett Hospital
Lawrenceville, Georgia, United States
LaGrange Memorial Hospital
La Grange, Illinois, United States
Iowa Heart Center
Des Moines, Iowa, United States
Via Christi Regional Medical center
Wichita, Kansas, United States
University of Kentucky medical Center
Lexington, Kentucky, United States
Baptist Hospital
Louisville, Kentucky, United States
Southwest Medical Center
Lafayette, Louisiana, United States
Greater Baltimore Medical Center
Baltimore, Maryland, United States
University of Massachusetts
Worcester, Massachusetts, United States
Bon Secours Cottage Health Center
Saint Clair Shores, Michigan, United States
Lakeland Regional Medical Center
Saint Joseph, Michigan, United States
St. Cloud Hospital
Saint Cloud, Minnesota, United States
Health Easst St. Joseph's Hospital
Saint Paul, Minnesota, United States
CV Surgical Clinic
Jackson, Mississippi, United States
St. Dominic-Jackson
Jackson, Mississippi, United States
Jeff Anderson Regional Medical Center
Meridian, Mississippi, United States
St. Luke's
Kansas City, Missouri, United States
Washington University School of Medicine
St Louis, Missouri, United States
St. John's Mercy Medical Center
St Louis, Missouri, United States
Dartmouth-Hitchcock
Lebanon, New Hampshire, United States
NMVA Healthcare
Albuquerque, New Mexico, United States
St. Luke's Healthcare
Utica, New York, United States
Mission Hospital
Asheville, North Carolina, United States
The Sanger Clinic-Carolinas Medical
Charlotte, North Carolina, United States
Kaiser Sunnyside
Clackamas, Oregon, United States
Pinnacle Health Hospital
Harrisburg, Pennsylvania, United States
Hahnemann Univeristy Hospital
Philadelphia, Pennsylvania, United States
Graduate Hospital
Philadelphia, Pennsylvania, United States
Providence Hospital
Columbia, South Carolina, United States
Lexington Medical Center
West Columbia, South Carolina, United States
North Central heart Institute
Sioux Falls, South Dakota, United States
Harlingen Medical Center
Harlingen, Texas, United States
St. Luke's Episcopal Hospital
Houston, Texas, United States
Houston Northwest Medical Center
Houston, Texas, United States
University of Vermont
Burlington, Vermont, United States
Henrico Doctors' Hospital
Richmond, Virginia, United States
St. Luke's medical Center
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Investigational Plan #025
Identifier Type: -
Identifier Source: org_study_id